InvestorsObserver
×
News Home

Does Heron Therapeutics Inc (HRTX) Have What it Takes to be in Your Portfolio Monday?

Monday, March 25, 2024 11:45 AM | InvestorsObserver Analysts

Mentioned in this article

Does Heron Therapeutics Inc (HRTX) Have What it Takes to be in Your Portfolio Monday?

The 85 rating InvestorsObserver gives to Heron Therapeutics Inc (HRTX) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 96 percent of stocks in the Biotechnology industry, HRTX’s 85 overall rating means the stock scores better than 85 percent of all stocks.

Overall Score - 85
HRTX has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on HRTX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 85 would rank higher than 85 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Heron Therapeutics Inc Stock Today?

Heron Therapeutics Inc (HRTX) stock has gained 0.95% while the S&P 500 is down -0.13% as of 11:43 AM on Monday, Mar 25. HRTX has gained $0.03 from the previous closing price of $2.97 on volume of 355,533 shares. Over the past year the S&P 500 is higher by 31.42% while HRTX has gained 73.41%. HRTX lost -$0.80 per share the over the last 12 months. Click Here to get the full Stock Report for Heron Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App